Clinical Trial Update: What is the Prognostic Value of HALP Score, Monocytopenia, Hypofibrinogenemia, and AST/ALT Ratio in Patients With Myelodysplastic Syndromes

View source ↗

Summary

A ClinicalTrials.gov entry outlining a study to assess the prognostic value of HALP score, monocytopenia, hypofibrinogenemia, and AST/ALT ratio in patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Snippet

Sponsor: Assiut University | Conditions: Myelo Dysplastic Syndrome | Status: NOT_YET_RECRUITING